{"id":"https://openalex.org/W1986378982","doi":"https://doi.org/10.1007/s10637-012-9819-5","title":"A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma","display_name":"A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma","publication_year":2012,"publication_date":"2012-04-26","ids":{"openalex":"https://openalex.org/W1986378982","doi":"https://doi.org/10.1007/s10637-012-9819-5","mag":"1986378982","pmid":"https://pubmed.ncbi.nlm.nih.gov/22539091"},"language":"en","primary_location":{"id":"doi:10.1007/s10637-012-9819-5","doi":"https://doi.org/10.1007/s10637-012-9819-5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-012-9819-5","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042631007","display_name":"Christopher W. Ryan","orcid":"https://orcid.org/0000-0002-4259-1123","observed_orcids":["https://orcid.org/0000-0002-4259-1123","https://orcid.org/0000-0003-1757-8311"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christopher W. Ryan","raw_affiliation_strings":["Section of Hematology/Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA. ryanc@ohsu.edu","Section of Hematology/Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA. ryanc@ohsu.edu","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]},{"raw_affiliation_string":"Section of Hematology/Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, USA","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103409642","display_name":"Chacon Matias","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125926","display_name":"Instituto Alexander Fleming","ror":"https://ror.org/02b0zvv74","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210125926"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Chacon Matias","raw_affiliation_strings":["Department of Medical Oncology, Instituto Alexander Fleming, Buenos Aires, Argentina","Instituto Alexander Fleming"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Instituto Alexander Fleming, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210125926"]},{"raw_affiliation_string":"Instituto Alexander Fleming","institution_ids":["https://openalex.org/I4210125926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031405616","display_name":"Mark Agulnik","orcid":"https://orcid.org/0000-0003-3513-3519","observed_orcids":["https://orcid.org/0000-0003-3513-3519"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Agulnik","raw_affiliation_strings":["Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA","Northwestern University****"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA","institution_ids":["https://openalex.org/I111979921"]},{"raw_affiliation_string":"Northwestern University****","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085410610","display_name":"Antonio Lopez Pousa","orcid":"https://orcid.org/0000-0003-1066-3951","observed_orcids":["https://orcid.org/0000-0003-1066-3951"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I2801795740","display_name":"Hospital de Sant Pau","ror":"https://ror.org/059n1d175","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2801795740"]},{"id":"https://openalex.org/I4210105141","display_name":"Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine","ror":"https://ror.org/01gm5f004","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210105141"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antonio Lopez-Pousa","raw_affiliation_strings":["Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, MICINN, ISCIII), Hospital de la Santa Creu I Sant Pau, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, MICINN, ISCIII), Hospital de la Santa Creu I Sant Pau, Barcelona, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I2801795740","https://openalex.org/I4210105141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062655853","display_name":"Charles C. Williams","orcid":"https://orcid.org/0000-0002-3698-1555","observed_orcids":["https://orcid.org/0000-0002-3698-1555"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Williams","raw_affiliation_strings":["Thoracic Department, Moffitt Cancer Center, Tampa, FL, USA","Thoracic Department, Moffitt Cancer Center, Tampa, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Department, Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Thoracic Department, Moffitt Cancer Center, Tampa, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076595940","display_name":"Dinesh P. de Alwis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Dinesh P. de Alwis","raw_affiliation_strings":["Global Pharmacokinetic/Pharmacodynamic Department, Eli Lilly and Company, Erlwood, UK","Merck Research Laboratories, Rahway, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Pharmacokinetic/Pharmacodynamic Department, Eli Lilly and Company, Erlwood, UK","institution_ids":["https://openalex.org/I4210095227"]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103547897","display_name":"Christopher J. Kaiser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Kaiser","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103409643","display_name":"Mary Alice Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Alice Miller","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051809626","display_name":"Sabine Ermisch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabine Ermisch","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031684939","display_name":"Robert L Ilaria","orcid":"https://orcid.org/0000-0002-6677-1794","observed_orcids":["https://orcid.org/0000-0002-6677-1794"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Ilaria","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Lilly Research Laboratories , Eli Lilly and Company , Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067158281","display_name":"Mary Louise Keohan","orcid":"https://orcid.org/0000-0002-8240-4900","observed_orcids":["https://orcid.org/0000-0002-8240-4900"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. L. Keohan","raw_affiliation_strings":["Department of Medicine, Melanoma and Sarcoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA","Memorial Sloan- Kettering Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Melanoma and Sarcoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Memorial Sloan- Kettering Cancer Center","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5042631007"],"corresponding_institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":1.03,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.79452162,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"31","issue":"1","first_page":"145","last_page":"151"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soft-tissue-sarcoma","display_name":"soft tissue sarcoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/metastatic-sarcoma","display_name":"metastatic sarcoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9620000123977661},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6359999775886536},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7289999723434448},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8080000281333923},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7360000014305115},{"id":"https://openalex.org/keywords/cmax","display_name":"Cmax","score":0.7900000214576721},{"id":"https://openalex.org/keywords/angiomyxoma","display_name":"angiomyxoma","score":0.5379999876022339},{"id":"https://openalex.org/keywords/angiosarcoma","display_name":"angiosarcoma","score":0.7360000014305115},{"id":"https://openalex.org/keywords/leiomyosarcoma","display_name":"leiomyosarcoma","score":0.8939999938011169},{"id":"https://openalex.org/keywords/desmoplastic-small-round-cell-tumor","display_name":"desmoplastic small round cell tumor","score":0.9900000095367432},{"id":"https://openalex.org/keywords/drug-safety-and-toxicity","display_name":"drug safety and toxicity","score":0.45399999618530273},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.3100000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7817809581756592},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7667523622512817},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.7109805345535278},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.6196996569633484},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.6160206198692322},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5783151388168335},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5689587593078613},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5412021279335022},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5149132013320923},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4985496997833252},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4499651789665222},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4363914728164673},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.4278796911239624},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3993460536003113},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.15547987818717957}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s10637-012-9819-5","doi":"https://doi.org/10.1007/s10637-012-9819-5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-012-9819-5","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},{"id":"pmid:22539091","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22539091","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational new drugs","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W171199456","https://openalex.org/W1943427806","https://openalex.org/W1966107654","https://openalex.org/W1966263910","https://openalex.org/W1979300931","https://openalex.org/W1989525615","https://openalex.org/W2004771737","https://openalex.org/W2057195209","https://openalex.org/W2082065626","https://openalex.org/W2095645261","https://openalex.org/W2098426299","https://openalex.org/W2100483340","https://openalex.org/W2107078868","https://openalex.org/W2114862111","https://openalex.org/W2116025938","https://openalex.org/W2139206468","https://openalex.org/W2139248078","https://openalex.org/W2150028075","https://openalex.org/W2157598836","https://openalex.org/W2159885083","https://openalex.org/W2162063003","https://openalex.org/W2168598691","https://openalex.org/W2246793900","https://openalex.org/W2249707777","https://openalex.org/W2398407510","https://openalex.org/W2498731549","https://openalex.org/W3198835821","https://openalex.org/W4293241248","https://openalex.org/W4323966471"],"related_works":["https://openalex.org/W2034899869","https://openalex.org/W2023592701","https://openalex.org/W2100483340","https://openalex.org/W2245332058","https://openalex.org/W2011827420","https://openalex.org/W7100444943","https://openalex.org/W2082638014","https://openalex.org/W1973131558","https://openalex.org/W2097409022","https://openalex.org/W2044944849"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}